Blog - The Purbottar

08 Jul

Reduction in syllabus a one-time measure, “Has Been Interpreted Differently” , says CBSE.

editor0 CommentsNorth East

Amid outrage and protests over the changes, the CBSE said the reduction or “rationalization” of syllabus for classes 9 to 12 had been "interpreted differently" and that it was a “one-time measure” to reduce the exam stress of students due to the health emergency and to prevent learning gaps.The national education board was responding to criticism it faced after k ey chapters like Democratic Rights, Food Security in India, Federalism, Citizenship and Secularism have been dropped from school courses to reduce the burden on students amid the coronavirus crisis. “The schools have also been directed to follow the alternative academic…

08 Jul

Arvind Kejriwal asks Health Secy to share detailed analysis

editor0 CommentsNorth East

Delhi Chief Minister Arvind Kejriwal has directed Delhi Health Secretary to share a detailed analysis of factors behind all COVID-19 deaths reported in the national capital in the last two weeks. The objective is to take measures to further reduce COVID19 deaths in the national capital which has so far reported 3,165 fatalities due to the highly-contagious disease. Meanwhile, the Delhi government has also directed all government and private COVID hospitals to get feedback from patients and their willingness to donate blood plasma after at the time of discharge.

08 Jul

Cipla Set To Undercut

editor0 CommentsHealth

Indian drugmaker Cipla Ltd has priced its generic version of Remdesivir, Cipremi, at 4,000 rupees ($53.34) per 100 mg vial, according to several sources, making it among the lowest priced versions of the COVID-19 treatment available so far globally. Cipla had earlier said pricing would not exceed 5,000 rupees. On Tuesday, Sovereign Pharma, which is manufacturing and packaging the drug for Cipla, said it had dispatched the first batch. Cipla business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000…

08 Jul

Amphan: Coca-Cola partners with Save the Children

editor0 CommentsBusinessAmphan, coca-cola

Coca-Cola in India with funding from The Coca-Cola Foundation has partnered with Save the Children to address the food security and shelter needs of affected victims of Cyclone AMPHAN, through a comprehensive relief assistance programme. The programme was rolled out in Kolkata in the presence of Sourav Ganguly, Mr Hemant Goenka, Managing Director, Diamond Beverages Pvt. Ltd. (DBPL), bottling partner of Coca-Cola in West Bengal. With over 1-lakh households displaced and 6-lakh people evacuated, this initiative will focus on aiding safe and hygienic drinking water, food security, shelter needs and livelihood in East Medinipur, Kolkata and South 24 Paraganas. Through…

08 Jul

Sony establishes Sony Research India

editor0 CommentsBusinessINDIA, SONY

Sony Corporation (‘Sony) announced that it established a research company ‘Sony Research India Private Limited’ (Sony Research India) effective July 1, 2020. Sony Research India consists of R&D Center India Bengaluru Laboratory and Mumbai Laboratory as part of Sony’s Global R&D centers. Through the establishment of Sony Research India, Sony will seek to leverage its multi-sites structure and talent for the excellence of its research. Sony Research India also aims to accelerate the collaboration with its entertainment and electronics business groups, while further enhancing competitiveness and capability of research and development in India. Sony Research India is also offering outstanding…

08 Jul

Glenmark’s Fabiflu for mild to moderate COVID-19 cases

editor0 CommentsBusinessCovid-19, Glenmarks

Over the past 5 months, since the first reported case of COVID-19, Glenmark mobilized its teams and development process started at its Research and Development (R&D) facility in Navi Mumbai. The entire process from R&D, to producing the Active Pharmaceutical Ingredient (API) at Ankleshwar (Gujarat) and manufacturing the formulations at Baddi (Himachal Pradesh) have been done in-house and is a significant achievement as part of “Make in India”. Despite investing significantly throughout the process of manufacturing FabiFlu, Glenmark has managed to keep the pricing of FabiFlu economical as compared to its price in other countries. FabiFlu in India costs Rs…

08 Jul

‘Covaxin’ Human Trial Process Begins at Hyderabad’s NIMS, Patna AIIMS

editor0 CommentsHealthAIIMS, Covid-19, NIMS

Now that India has developed its first indigenous COVID-19 vaccine, Covaxin, it has started its preparations to begin the much-awaited human clinical trials. Covaxin will be tested on more than 1100 people. The vaccine developed by the Bharat Biotech recently got the green signal from ICMR and the apex body has given nod to a total of 12 hospitals to begin preparations to conduct human clinical trials. Two of them include Hyderabad’s Nizam’s Institute of Medical Sciences and Patna-based All India Institute of Medical Science (AIIMS) As per reports, the human trial will take at least 6 to 8 months to…

07 Jul

Covaxin trial to start at Belagavi hospital , India’s first COVID-19 vaccine to begin soon.

editor0 CommentsNorth East

Covaxin, the first possible vaccine against COVID-19, will be tested on a team of around 200 healthy volunteers in and around Belagavi. The clinical trials will be conducted by doctors and staff members of Jeevan Rekha, a multi-speciality hospital here, monitored by the Indian Council of Medical Research (ICMR) and Bharat Biotech International Ltd., the private company that has developed the chemical molecule, doctors at the hospital said. Jeevan Rekha is one of the 12 hospitals and health centres in the country chosen by the Union government for clinical trials of the vaccine, whose technical name is BBV152 COVID vaccine.…

07 Jul

Reopened monuments wear a deserted look on first day.

editor0 CommentsNorth East

India on Monday tentatively stepped out of a 75-day lockdown with malls, religious places and offices opening in several parts of the country under strict conditions limiting the number of people and mandating sanitisation of all premises. Monuments that reopened to the public on Monday after being closed in March due to the COVID-19 pandemic wore a deserted look on the first day, with more media persons than visitors at the sites. Culture Minister Prahlad Singh Patel had announced on July 2 that all Centrally protected monuments of the Archaeological Survey of India that were located outside containment zones would…

07 Jul

UGC decides to conduct Final Year university exam by September end.

editor0 CommentsNorth East

Final Year university examinations may be postponed until the end of September, but must be conducted in either online or offline mode, the University Grants Commission (UGC) decided on Monday evening. Students who are unable to appear for these examinations will be given the opportunity to appear for special examinations which will be conducted later, according to an official statement. The UGC had first released an indicative academic calendar for higher education institutions on April 29 in which it had prescribed that universities conduct their final-year or terminal semester examination from July 1 to July 15 and declare their results…